| Dr Alessandra Anna Secco, MD | |
|
7900 N Milwaukee Ave Ste 231a, Niles, IL 60714-3247 | |
| (847) 663-9400 | |
| Not Available |
| Full Name | Dr Alessandra Anna Secco |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 10 Years |
| Location | 7900 N Milwaukee Ave Ste 231a, Niles, Illinois |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265859607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 036141906 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Christ Hospital & Medical Center | Oak lawn, IL | Hospital |
| Palos Community Hospital | Palos heights, IL | Hospital |
| Presence St Marys Hospital | Kankakee, IL | Hospital |
| Advocate Trinity Hospital | Chicago, IL | Hospital |
| Riverside Medical Center | Kankakee, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metro Infectious Disease Consultants Llc | 3072425784 | 297 |
News Archive
The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.
Kinex Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has allowed its Investigational New Drug (IND) application for Oratecan, an oral form of an approved anti-cancer drug irinotecan with enhanced oral absorption.
FundamentalVR, pioneers of immersive training technology for the medical community, today launched Fundamental Surgery, a first-of-its-kind SaaS software platform that combines virtual reality with cutting-edge haptics (the sense of touch) to create a low-cost and scalable flight simulator experience for trainee and qualified surgeons.
Witnessing a person from our own group or an outsider suffer pain causes neural responses in two very different regions of the brain. And, the specific region activated reveals whether or not we will help the person in need. Researchers at the University of Zurich studied the brain responses of soccer fans and now have neurobiological evidence for why we are most willing to help members of our own group.
› Verified 8 days ago
| Entity Name | Metro Infectious Disease Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235125717 PECOS PAC ID: 3072425784 Enrollment ID: O20031103000274 |
News Archive
The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.
Kinex Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has allowed its Investigational New Drug (IND) application for Oratecan, an oral form of an approved anti-cancer drug irinotecan with enhanced oral absorption.
FundamentalVR, pioneers of immersive training technology for the medical community, today launched Fundamental Surgery, a first-of-its-kind SaaS software platform that combines virtual reality with cutting-edge haptics (the sense of touch) to create a low-cost and scalable flight simulator experience for trainee and qualified surgeons.
Witnessing a person from our own group or an outsider suffer pain causes neural responses in two very different regions of the brain. And, the specific region activated reveals whether or not we will help the person in need. Researchers at the University of Zurich studied the brain responses of soccer fans and now have neurobiological evidence for why we are most willing to help members of our own group.
› Verified 8 days ago
| Entity Name | Northwest Infectious Disease Consultants, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194775221 PECOS PAC ID: 5395636914 Enrollment ID: O20040323001105 |
News Archive
The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.
Kinex Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has allowed its Investigational New Drug (IND) application for Oratecan, an oral form of an approved anti-cancer drug irinotecan with enhanced oral absorption.
FundamentalVR, pioneers of immersive training technology for the medical community, today launched Fundamental Surgery, a first-of-its-kind SaaS software platform that combines virtual reality with cutting-edge haptics (the sense of touch) to create a low-cost and scalable flight simulator experience for trainee and qualified surgeons.
Witnessing a person from our own group or an outsider suffer pain causes neural responses in two very different regions of the brain. And, the specific region activated reveals whether or not we will help the person in need. Researchers at the University of Zurich studied the brain responses of soccer fans and now have neurobiological evidence for why we are most willing to help members of our own group.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alessandra Anna Secco, MD 7900 N Milwaukee Ave Ste 231a, Niles, IL 60714-3247 Ph: (847) 663-9400 | Dr Alessandra Anna Secco, MD 7900 N Milwaukee Ave Ste 231a, Niles, IL 60714-3247 Ph: (847) 663-9400 |
News Archive
The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.
Kinex Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has allowed its Investigational New Drug (IND) application for Oratecan, an oral form of an approved anti-cancer drug irinotecan with enhanced oral absorption.
FundamentalVR, pioneers of immersive training technology for the medical community, today launched Fundamental Surgery, a first-of-its-kind SaaS software platform that combines virtual reality with cutting-edge haptics (the sense of touch) to create a low-cost and scalable flight simulator experience for trainee and qualified surgeons.
Witnessing a person from our own group or an outsider suffer pain causes neural responses in two very different regions of the brain. And, the specific region activated reveals whether or not we will help the person in need. Researchers at the University of Zurich studied the brain responses of soccer fans and now have neurobiological evidence for why we are most willing to help members of our own group.
› Verified 8 days ago
Susan G Brown, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 8915 W Golf Rd, Niles, IL 60714 Phone: 847-827-9060 Fax: 847-827-7196 | |
Kirill Zhadovich, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7900 N Milwaukee Ave, Suite 2-24, Niles, IL 60714 Phone: 847-825-0800 Fax: 847-825-0803 | |
Dr. Jorge A Aliaga, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 241 Golf Mill Ctr, 728, Niles, IL 60714 Phone: 847-635-7840 Fax: 847-635-6491 | |
Sufyan Abdulmujeeb, Infectious Disease Medicare: Medicare Enrolled Practice Location: 7900 N Milwaukee Ave Ste 19, Niles, IL 60714 Phone: 847-318-9595 Fax: 847-318-9599 | |
James S Poulos, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 7157 W Howard St, Niles, IL 60714 Phone: 847-647-1771 | |
Dr. Gary Richard Fahrenbach, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7411 N Milwaukee Ave, Niles, IL 60714 Phone: 773-763-1818 Fax: 773-763-9381 | |
Dr. Dean Silas, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7900 Milwaukee Ave, Suite 19, Niles, IL 60714 Phone: 847-318-9595 Fax: 847-318-9599 |